Thematic photoMartin FalbisonerCC BY-SA 3.0Resized, encoded as WebP; displayed with responsive cropping under the original licenceSEC EDGAR published this disclosure on 2026-09-04. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0001437749-26-029732
acquired disposedA
codeP
direct or indirectD
form4
is derivativefalse
issuer nameBioCardia, Inc.
labelOpen market purchase
Source record & verificationDates, provenance and technical details
Context
links are based on the recorded entity typeRecorded payloadStructured source data
Recorded payload
JSON payload as stored after parsing{
"accession": "0001437749-26-029732",
"acquired_disposed": "A",
"code": "P",
"direct_or_indirect": "D",
"form": "4",
"is_derivative": false,
"issuer_name": "BioCardia, Inc.",
"label": "Open market purchase",
"person_name": "Altman Peter",
"price": 1.09,
"role": "Director, President and CEO",
"security": "Common Stock",
"shares": 800,
"shares_owned_after": 381985,
"source_path": "edgar/data/1647542/0001437749-26-029732.txt",
"ticker": "BCDA",
"transaction_date": "2026-09-03",
"value": 872.0000000000001
}Evidence-based analysis
facts, provenance and explicit model coverageDescriptive evidence from the stored source record; it is not advice, a forecast or a legal conclusion.